ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

On More Victory For Sol Garb: FDA Approves THC

June 14, 1985

Komen Board Approved Defunding Planned Parenthood, Says Karen Handel

February 10, 2012

In Brief: City of Hope launches Hematologic Malignancies and Stem Cell Transplantation Institute

October 31, 2014

“Mind Boggling” Results Reported In Trials Using 3-Drug Combination For Breast Cancer

October 10, 1975

Clarification: Full Text Of ACS Guideline On Prostate Screening

January 30, 1998

Drug Shortages: Institutions Report Halting Enrollment in Clinical Trials

March 22, 2013